These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 11827003)
1. Scanning electron microscopic study of a Ciloxan bottle blocked by ciprofloxacin crystals. John T Eye (Lond); 2001 Dec; 15(Pt 6):786-8. PubMed ID: 11827003 [TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of the white precipitate formed on the corneal surface after treatment with ciprofloxacin ophthalmic solution. Madhavan HN; Rao SK; Joseph PR; Sulochana KN Cornea; 1999 Sep; 18(5):549-52. PubMed ID: 10487428 [TBL] [Abstract][Full Text] [Related]
4. Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers. Booranapong W; Kosrirukvongs P; Prabhasawat P; Srivannaboon S; Suttiprakarn P J Med Assoc Thai; 2004 Mar; 87(3):246-54. PubMed ID: 15117040 [TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy of ciprofloxacin 0.3%9 (Ciloxan) in the treatment of bacterial infections of the external eye segment]. Stankiewicz A; Kosatka M; Goś A Klin Oczna; 2003; 105(6):407-9. PubMed ID: 15049266 [TBL] [Abstract][Full Text] [Related]
6. Topical ciprofloxacin for bacterial corneal ulcer. Kosrirukvongs P; Buranapongs W J Med Assoc Thai; 2000 Jul; 83(7):776-82. PubMed ID: 10932513 [TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium. Eiferman RA; Snyder JP; Nordquist RE J Cataract Refract Surg; 2001 Oct; 27(10):1701-2. PubMed ID: 11687375 [TBL] [Abstract][Full Text] [Related]
8. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708 [TBL] [Abstract][Full Text] [Related]
9. Deposits of topical norfloxacin in the treatment of bacterial keratitis. Castillo A; Benitez del Castillo JM; Toledano N; Diaz-Valle D; Sayagues O; Garcia-Sanchez J Cornea; 1997 Jul; 16(4):420-3. PubMed ID: 9220239 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. Kunimoto DY; Sharma S; Garg P; Rao GN Ophthalmology; 1999 Jan; 106(1):80-5. PubMed ID: 9917785 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of two chondroitin sulfate ophthalmic solutions in the therapy of spontaneous chronic corneal epithelial defects and ulcerative keratitis associated with bullous keratopathy in dogs. Ledbetter EC; Munger RJ; Ring RD; Scarlett JM Vet Ophthalmol; 2006; 9(2):77-87. PubMed ID: 16497231 [TBL] [Abstract][Full Text] [Related]
12. Ocular bioerodible minitablets as strategy for the management of microbial keratitis. Weyenberg W; Vermeire A; Dhondt MM; Adriaens E; Kestelyn P; Remon JP; Ludwig A Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3229-33. PubMed ID: 15326145 [TBL] [Abstract][Full Text] [Related]
13. Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model. Stevens RK; Holland GN; Paschal JF; Phinney RB; Berlin OG; Bruckner DA Cornea; 1992 Nov; 11(6):500-4. PubMed ID: 1468211 [TBL] [Abstract][Full Text] [Related]
15. Ciloxan for the management of corneal ulcers. Scott A J Ophthalmic Nurs Technol; 1991; 10(5):207-10. PubMed ID: 1942101 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of topically applied ciprofloxacin in equine tears. Hendrix DV; Stuffle JL; Cox SK Vet Ophthalmol; 2007; 10(6):344-7. PubMed ID: 17970994 [TBL] [Abstract][Full Text] [Related]